Research Matters - Issue 4

Page 1

Research Matters

News from across NHS Research Scotland (NRS) Issue 4 | September 2016

Delivering Research Excellence Welcome to our new Head of 3 Boost for Precision Medicine research 5 NHS Research Scotland Annual Conference 7 Imaging 9 News from the network...pages 11 - 13 A new look 17

Much more inside...

NHS Research Scotland

Delivering Research Excellence... The research landscape is ever evolving and maintaining our position at the forefront of health research requires strong leadership, investment in staff and facilities and innovative approaches to healthcare. Approaches that allow our NHS to be effective in delivering high quality health care while being efficient with limited resources. This issue of Research Matters is all encompassing. We welcome Ricky Verall, our new Head of Chief Scientist Office (CSO) on Page 3 and thank predecessor Mike Stevens for his work in transforming the research environment in Scotland. Further praise for services to medical science are recognised on Page 4 with Professor Anna Dominiczak appointed Dame Commander in recognition of her services to cardiovascular and medical science. Professor Dame Anna Dominiczak has also been a driving force in positioning Scotland as a global leader in precision medicine and on Page 6 we celebrate the University of Glasgow being honoured with a Regius Professorship of Precision Medicine one of 12 new Regius Professorships announced to celebrate Her Majesty’s 90th birthday. A further boost to research is acknowledged with the delivery of the first MR-PET system in Scotland to Edinburgh and the first clinical 7T MR system in Scotland due to be installed at the Queen Elizabeth University Hospital in Glasgow. As the birthplace of medical ultrasound imaging and MRI, these new world class facilities ensure Scotland sustains its position of excellence in imaging and helps secure significant research investment which you can read more about on Page 9.

developments across our networks on Pages 13 - 16 and how we are working to ensure national standards for researchers on Page 11. Research and innovation go hand in hand when it comes to improving health and patient care so we are also delighted to share the latest developments from Scottish Health Innovations Ltd on Page 17 including a brand new website and details of the Innovation Award at the upcoming Scottish Health Awards. As ever a busy time across NHS Research Scotland but lots to be positive about as we enter the second half of the year. We will be using the annual NRS Conference as an opportunity to come together, reflect on progress and achievements and explore the challenges in this evolving landscape. Read more about the conference on Page 7 and register soon if you have not already. We look forward to seeing you there. NHS Research Scotland Strategy Board Dr Alan McNair (Interim Chair)

Interim Head of Chief Scientist Office Professor Julie Brittenden

R&D Director, NHS Greater Glasgow & Clyde Professor Maggie Cruikshank

Acting R&D Director , NHS Grampian Dr Jacob George

R&D Director, NHS Tayside Professor Dave Newby

R&D Director, NHS Lothian

Supporting these investments with a solid infrastructure and efficient, streamlined processes is essential so read more about

NHS Research Scotland


In this edition: 

Changing faces at Chief Scientist Office - Page 3

Glasgow scientist named Dame in Queens Birthday honours - Page 4

Boost for precision medicine research - Pages 5 - 6

Annual NHS Research Scotland conference - Pages 7 - 8

World class imaging facilities - Page Health network - Pages 9 - 10

Supporting efficiency - overview of Generic Review process - Pages 11 - 12

Latest updates from Mental Health Network - Pages 13 - 14

Neuroprogressive and Dementia - Pages 15 - 16

Supporting innovation across NHS Scotland - Pages 17 - 18

Get in touch

Research Bulletin

Send articles, photographs or feedback to:

Remember our monthly e-bulletin is issued the first week of each month.

e: t: 0141 951 5508

Publication Dates Issue


Autumn (October)

5 October 2016

Winter (January)

16 December 2016

Spring (April)

3 April 2017

Contributions from across the research community are vital to sustain the publication and ensure relevance.

Research Look out for it in Bulletin your inbox!

If you don’t receive you can subscribe via Insert your email address at the foot of the webpage beside ‘Newsletter’

Get in touch Send articles, photographs or feedback to: e:


Welcome to Ricky Verrall... New Head of Chief Scientist Office (CSO) Ricky Verrall has been appointed as Head of CSO and took up position on Monday 29 August. Bringing considerable experience from previous roles in Scottish Government, including Health Care Quality Strategy, Human Resources, Workforce Planning as well as roles in the Environment Division and Department of Business Innovation and Skills, Ricky will lead the CSO team delivering on the ambitions set out in the Health and Social Care Research Strategy (2015). Commenting on his new post, Ricky said: “Health research is one of this country’s key strengths and I look forward to working with colleagues to support and increase the level of high-quality research conducted in Scotland. With a strong reputation, excellent infrastructure and world class clinical and academic expertise, we have an excellent platform to deliver the ambitious agenda set out in our recent strategy, and sustain Scotland’s reputation as a health science nation.”

Farewell from Mike Stevens... New Head of Chief Scientist Office (CSO) Mike was appointed to the new post of Head of the Chief Scientist Office in 2014, but had been part of CSO since 1999 when he joined as Deputy Director. Mike was responsible for the creation and development of NHS Research Scotland (NRS) making Scotland a more attractive place to conduct clinical trials, and driving collaboration through all Health Boards in Scotland. Mike commented: “I have greatly enjoyed working with you all and believe together, through NRS and your hard work, we have transformed research into an efficient and highly regarded organisation that is now receiving international recognition. “I now plan to spend more time travelling in Europe and allow my work to be progressed by younger blood. I thank you for your hard work, support and friendship over the years,”

NHS Research Scotland


Queens Birthday Honours Professor Anna Dominiczak appointed Dame Commander Commenting on the award, Professor Dame Anna Dominiczak said: “I am extremely proud to receive this honour and consider it also a recognition of the work of my many dedicated, talented and inspiring colleagues at the University of Glasgow. Their support has been invaluable.

Professor Anna Dominiczak, Regius Professor of Medicine, Vice-Principal and Head of the College of Medical, Veterinary and Life Sciences, has been appointed a Dame Commander of the Order of the British Empire in recognition of her services to cardiovascular and medical science. A graduate of the Medical School in Gdansk, Poland, and one of the world’s most eminent cardiovascular scientists and academics, Professor Dominiczak is also an honorary consultant physician and non-executive director of the NHS Greater Glasgow and Clyde Health Board. Her research into hypertension, cardiovascular genomics and precision medicine identifies genetic factors which may predispose people to heart disease and stroke. She has authored almost 400 research publications and is currently Editor-in-chief of Hypertension, the world's top medical journal on high blood pressure. Professor Dominiczak was also instrumental in creating the British Heart Foundation Cardiovascular Research Centre, of which she was Director from 2000-10. In 2010 she became Vice-Principal and Head of the College of MVLS at the University of Glasgow and has been a driving force in positioning Scotland as a global leader in precision medicine.

“ It is indeed an honour for me to lead the work of the College of Medical, Veterinary and Life Sciences which excels across so many areas and it is my hope that we can continue to positively transform the outcomes for so many people with cardiovascular and other chronic diseases.” “I am blessed with an outstanding team and we have achieved many things together in the field of cardiovascular science, especially at the Queen Elizabeth University Hospital.”

Professor Dame Anna Dominiczak will be presenting during our Annual NHS Research Scotland Conference at Queen Elizabeth Teaching and Learning Centre on 26 October 2016. For further information visit:


Boost for Precision Medicine research Glasgow University celebrates prestigious accolade The University of Glasgow has been honoured with a Regius Professorship of Precision Medicine one of 12 new Regius Professorships announced to celebrate Her Majesty’s 90th birthday. The title of Regius Professorship is a rare and prestigious award bestowed by the Sovereign to recognise exceptionally high quality research at an institution. Only 14 have been granted since the reign of Queen Victoria, including 12 to mark Her Majesty’s Diamond Jubilee. The University of Glasgow is at the forefront of Precision Medicine, which is widely recognized as being the future of medicine, in that it will transform healthcare both in the UK and globally. Recent advances are helping facilitate Precision Medicine’s aims to deliver the right medicine for the right patient at the right time, selecting treatments with more predictable, safer, and cost-effective outcomes. In partnership with NHS Greater Glasgow & Clyde, the University of Glasgow is leading the world in driving forward this modern medicine and is at the heart of Scotland’s internationally recognised precision medicine ecosystem. The creation of a Regius Professorship in Precision Medicine formally recognises the transformative development, advancement and delivery of precision medicine by the university and the role will provide academic leadership for this area of innovative work. The university’s internationally recognised pre-eminence in precision medicine, long established expertise in clinical trials and the new developments at the heart of The Queen Elizabeth University Hospital have created the ideal environment for translating research into real patient benefit. This Regius Chair will celebrate and provide overarching leadership to this exciting programme A Royal Warrant will be issued formally conferring the new Regius Professorship and the announcement of who will be given the honour will be made in due course. For further details visit University of Glasgow website.


“I am delighted to hear the announcement that the University of Glasgow is to be awarded a new Regius Professorship of Precision Medicine, and I would like to thank Her Majesty for creating this esteemed new post. “Such a prestigious Chair underlines the strategic importance of Precision Medicine to the University and recognises the terrific potential this innovative branch of medical science has to bring real health benefits to our communities. “The university looks forward to appointing a deserving candidate to take up this exciting role.” Professor Anton Muscatelli, Principal and Vice-Chancellor University of Glasgow


The annual NHS Research Scotland Annual Conference is fast approaching. With over 400 delegates, more than 40 speakers and lots of new additions to the programme, 2016 set to be the biggest and best conference yet , featuring: 

More parallel session options

More exhibitors and networking time

More high profile speakers

We are also excited to launch the first NRS Conference event app—giving you all the information you need to make the most of the day in the palm of your hand!

Stay up to date

@NHSResearchScot #NRSConf16

0141 951 5508

Exhibition Exciting changes to the Exhibition area are planned with focussed ‘Zones’ showcasing Scotland’s research strengths and capabilities across:





If you are still interested in exhibiting there are a small number of places still available. Read more at or contact

Event App It seems like you get an app for everything now and the Annual NHS Research Scotland conference is no different. Providing all the information you need in the palm of your hand the app will provide personalised programmes based on your session choices, easy navigation around the venue, access to speaker information, exhibitor details and social features. With the added benefit of reducing our environmental impact. Available to download from the App stores in early October. Look out for more information via @NHSResearchScot #NRSConf16

NHS Research Scotland


Plenary Speakers

Professor Andrew Morris

Professor Dame Anna Dominiczak

Paul Gray

Chief Scientist (Health)

Regius Professor of Medicine

Director General Health & Social Care and Chief Executive NHS Scotland

University of Glasgow

A further 40+ speakers will feature within our parallel sessions. Read more at

Shona Robison MSP

Professor Siddharthan Chandran

Cabinet Secretary for Health & Sport

MacDonald Professor of Neurology University of Edinburgh

Getting there... Dedicated return coach transfers will run to and from Glasgow Queen Street Station and Glasgow Central Station. Coaches will depart each station at approx. 9.00am and depart Queen Elizabeth Teaching and Learning Centre at approx. 4.40pm for return journey. Journey time is estimated at approx. 30 minutes taking account of traffic. Places must have been booked at the registration stage. Further travel information is available at


World Class Imaging Facilities Scotland boosts reputation with new equipment portfolio It is an exciting time for imaging across Scotland as several new world-class facilities gear up to open. The first MR-PET system in Scotland, a Siemens Biograph mMR is being installed at the Clinical Research Imaging Centre (CRIC) in Edinburgh (funded by Dementias Platform UK); and the Brain Research Imaging Centre (BRIC) has just taken delivery of a neuro-optimised Siemens 3T wholebody MR scanner based in BRIC2 near the Royal Infirmary of Edinburgh A&E department. Over in Glasgow, the University of Glasgow has almost completed its new Imaging Centre of Excellence (ICE) at the new Queen Elizabeth University Hospital (QEUH). ICE will include the first 7 Tesla MRI scanner in the UK (a Siemens MAGNETOM Terra) to be located in a hospital campus and specifically designed to be accessible to patients of all types, including stroke. The £32million ICE, opening in early 2017, will accommodate clinical academic imaging specialists, NHS clinical physics expertise, innovation space for medical imaging companies and other SMEs, and also a suite of NHS neuro operating theatres. ICE will be physically linked to the QEUH, the Stratified Medicine Scotland Innovation Centre, new Clinical Research Facilities for clinical trials, and an Innovation Floor for industry. Academic and medical imaging research across the facilities enhanced by these state-of-the-art systems is centrally represented by ‘Scottish Imaging Network: A Platform for Scientific Excellence’ (SINAPSE), a network that creates a shared national environment for strategic research, education, and knowledge exchange. Significant investments in advanced imaging technology complement great recent success by leading SINAPSE members in securing large EU grants. The impressive list of Horizon 2020 Awards includes: 

a €4 million PET Imaging in Drug Design and Development ITN grant to Professor Matteo Zanda at the University of Aberdeen

a €6.6 million project on Improving Diagnosis by Fast Field-Cycling MRI to Professor David Lurie at the University of Aberdeen

a €6 million grant for a multicentre study to understand mechanisms of stroke and dementia to Professor Joanna Wardlaw at the University of Edinburgh

This is a snapshot of some of the exciting developments in imaging across Scotland. As the birthplace of medical ultrasound imaging and MRI, Scotland works hard to maintain its position of excellence. SINAPSE - a partnership of six Scottish Universities: Aberdeen, Dundee, Edinburgh, Glasgow, St. Andrews, and Stirling - makes best use of Scottish facilities and expertise in medical imaging and develops skills for the next generation of professionals working in this field. If you are involved in imaging research in Scotland, then you are invited to join SINAPSE. Membership is free and open to anyone in Scotland involved in research that uses MRI, CT, PET, SPECT, EEG, MEG, ultrasound, or human optical imaging.

NHS Research Scotland



National standards to support clinical research NRS process summary Scotland operates a centralised system to support clinical research in Scotland and improve quality, efficiency and co-ordination. Working on a pan-Scotland basis a responsive infrastructure has been implemented to encourage researchers to bring studies to Scotland and ensure that obtaining R&D permission is a smooth and rapid process. Our national system integrates fully with the rest of the UK, ensuring that clinical researchers in Scotland receive proportionate and timely approval for their projects.

Staged process: Researchers submit project information using the UKwide IRAS portal Relevant documents can be uploaded here such as:  Study Protocol  Contracts  Agreements Exact requirements will differ depending on the study but are clearly shown on the IRAS system. NRS Permissions Co-ordinating Centre in Aberdeen is the next point of contact for all commercially sponsored research and for multi-centre non-commercial research Contact: Responsibility for submission of documents depends on whether the study is commercial, non - commercial, single or multi-site, Scotland or UK wide.

Commercial and non-commercial multicentre studies led from Scotland The Sponsor/Chief Investigator (or delegated responsibility) submits paperwork via email to NRS PCC.

Non-commercial studies led from elsewhere in UK with Scottish sites Lead co-ordinating centre in the other UK nation submits paperwork via email to NRS PCC.

Commercial studies open elsewhere in UK with Scottish sites Sponsor submits paperwork via email to NRS PCC

NHS Research Scotland


Permissions Co-ordinating Centre (PCC) - A central role… 

Once the study is determined as either commercial or non-commercial, the document set is checked and validated. This can be completed in 1 day.

Projects are then passed to one of four nodes across the country who are responsible for undertaking the Generic Review to consider any issues across all participating sites. This includes contracts, costs plus identification and assessment of any risks. Node

Generic Reviewer



Maria R. Amezaga


Liz Coote


Kenny Scott


Ross Nicol


To ensure correspondence is actioned promptly - the generic mailboxes noted above should be used rather than individual contacts. 

Generic Reviews are expected to be complete within a total of 10 days

Once the study has been approved the Generic Reviewer will issue a Study-wide Governance report, which applies to all participating sites.

Permissions Co-ordinating Centre will then pass this to lead co-ordinating centres in any other participating UK nations. Working in parallel... 

The Generic Review process operates in parallel with local approval which begins when both a full document set is received by PCC, or when the researcher submits a signed and locked Site Specific Information (SSI) form, generated from IRAS and emailed at the local R&D office where the research will be conducted.

The later of the two start dates applies to the start of the local review timelines

Researchers can submit SSIs at any time after discussion with the local R&D office

Closely monitored system to ensure NRS provides best service to researchers.

12 working days Combined approval times (July 2016)

The Health Research Authority (HRA) have changed the process for local approval of English sites. Researchers CAN still submit SSI forms to HRA who will use them to generate the forms required in England.


Supporting research in priority areas

Mental Health is one of the major public health challenges in Scotland. Around one in four people are estimated to be affected by mental ill-health in any one year. Scotland’s mental health research community is active in leading research in areas such as schizophrenia, bipolar disorder, autism, depression, addictions and psychosis. The Scottish Mental Health Research Network provides support to improve the quality and quantity of research and promote excellence in mental health clinical research. Support extends to commercial and academic studies across a wide range of areas including imaging, psychosocial, genetic, multi-centre clinical trials, and e-health research. To deliver this ambitious agenda the network has undergone a number of exciting changes...

New staff Laura Hodges has become the Network Manager and Kate McAllister has been appointed Network Research Coordinator. The Network have also welcomed new Research Nurses and Research Assistants - Tessa Coupar (Dundee), Alice Adams (Aberdeen) , Andrea Clark (Glasgow), Anders Jespersen and Dawn Gray (Edinburgh). Supporting research out with the major academic centres and in a wider variety of Health Boards will be a focus for these new staff and we wish them well in their new roles.

Patient and Public Involvement Patient and Public Involvement is integral to the Networks approach to supporting research. Activity is informed by interactions with service users, coupled with ongoing relationships with organisations such as the Mental Health Foundation. Public and patient outreach will continue through 2016-17 through hosted service user focus groups and increased activity on social media channels such as Twitter.

Increased efforts to engage more clinicians across the country in mental health research and maximise resources for facilitating research in Scotland will also be a focus.

NHS Research Scotland


Future Research Championed by Professor Stephen Lawrie, the network will continue to support all eligibly funded research studies and expand the academic and commercial portfolio into areas at the cutting edge of mental health. For example, very little is currently known about resilience and risk factors in psychiatry and the network are supporting studies led from Scotland that are going some way to address this. These include:  

Stratifying Resilience and Depression Longitudinally (STRADL), a risk factor study funded by a Wellcome Trust Strategic grant Youth Mental Health Risk and Resilience Study (YouR-Study), which uses brain imaging techniques to help understand risk factors for psychosis

Mental health research in the coming years will be aided by the rise in ‘big data’ studies and in informatics more widely, the benefits of which will be outlined in an upcoming paper in Lancet Psychiatry. Whilst clinical trials remain the gold standard of all treatment research, there is an increasing interest in the use of technology in mental health research, as well as care, and in using new approaches to test these. This includes the use of virtual reality and the development of apps, such as EMPOWER, an SMHRN-supported study based in Glasgow designed to aid monitoring of symptoms and promotion of wellbeing. New approaches to care and research will require novel methods of evaluation therefore ethical and scientific discussions around innovation and big data are at the forefront of the Annual Scottish Mental Health Network Scientific Meeting, which takes place on the 4th of October in Edinburgh. Co-hosted with the Farr Institute and MQ, confirmed speakers include Professor Matthew Hotopf and Professor Jill Pell. The conference will appeal to clinicians, researchers and service users alike, showcasing Scotland’s best clinical research in mental health.

Scottish Mental Health Network Annual Scientific Meeting Tuesday 4 October, Royal College of Surgeons This year’s theme is Mental Health Research in the Digital Age. Topics covered will include informatics, e-health, patient and public perspectives and wearables. Mental Health areas covered will include suicide, learning disability and depression. Proudly partnered with:

For further details please contact @SMHRN1


Supporting inter-disciplinary Research Neuroprogressive and Dementia Network Dementia is one of the foremost public health challenges worldwide. As a consequence of improved healthcare and better standards of living more people are living for longer. This means in Scotland that the number of people with dementia is expected to double between 2011 and 2031. At the same time neurodegenerative diseases including Motor Neurone Disease, Parkinson’s Disease, Huntington’s Disease, and Multiple Sclerosis are increasingly understood to have commonality in underlying causes, patient experience, symptoms and their management. To advance understanding of the diseases and new treatments, inter-disciplinary research is crucial and the newly named Neuroprogressive and Dementia Network (NDN) supports a wide range of research studies conducted within the NHS and Care Home settings including: 

research into the underlying mechanisms and causes


new symptoms

disease-modifying treatments

better care

Paving the way for novel interventions Tackling memory interference The Scottish Neuroprogressive and Dementia Network (NDN) has supported a collaborative and interdisciplinary research project led by neuropsychologist Dr Michaela Dewar (Heriot-Watt University) and neurophysiologist Dr Iris Oren (University of Edinburgh) focussed on tackling memory interference. The project builds on the recent finding by Michaela Dewar and her team that people with Alzheimer’s Disease (AD) and amnestic Mild Cognitive Impairment (aMCI) recall much more new information if they rest in the period that immediately follows learning than if they engage in a mentally engaging task in the period that immediately follows new learning. This finding suggests that people with aMCI and AD can still lay down new memories but that new information interferes substantially with this laying down process, thus causing severe forgetting. The new collaborative project aims to shed light on the causes of this severe memory interference, with the overarching aim of paving the way for novel therapeutics that can improve memory by reducing interference. To this end, the psychologists and animal neuroscientists have joined forces, examining memory interference at the neural, network and behavioural level.

NHS Research Scotland


Thanks to the award, researchers were able to appoint two talented undergraduate students to undertake summer internships in their labs, as well as supporting key pilot studies run by Postdoctoral Research Associate Dr Michael Craig (Heriot-Watt University). Below we learn more about what the team have been working on.

Cognitive Psychologist

Working with Michaela Dewar, cognitive psychologist Michael Craig has developed two novel computerized memory tasks for future AD research. The tasks test a person’s memory for recently viewed objects, both after a rest period and after a game period. Michael’s recent pilot work shows that the object task allows for a detailed analysis of memory interference effects, thus making it a valuable novel task for future research investigating the brain basis of memory interference in AD patients. Moreover, the non-verbal nature of the task allows for a more straightforward comparison and translation of the human and animal (see below) findings. Thanks to the award, Michael has also been able to complete further pilot work on a virtual reality task, in which people have to learn to navigate in a new town. This research and task have fueled a novel human brain imaging study with collaborators in Germany.

Rachel Hastie

Rachael Hastie undertook her summer internship within the Psychology Department at Heriot-Watt University, where she was supervised by Dr Michaela Dewar and Dr Michael Craig. In her project Rachael co-developed and piloted a novel task to be used in future human brain imaging research examining changes in memory-related brain activity during rest and task periods. Having enjoyed her research experience so much, Rachael has continued to work on her project as a voluntary research assistant, and we look forward to analysing her data in due course. Moreover, the project has inspired Rachael to pursue a PhD on memory interference and enhancement (pending PhD funding)

Emily Carroll

Emily Carroll undertook her summer internship in the University of Edinburgh’s Centre for Cognitive and Neural Systems where she was jointly supervised by Drs. Iris Oren and Oliver Hardt. Her project aimed to establish a rodent behavioural task to parallel the human task developed by Michaela Dewar. Emily developed a protocol in which she tested mice on their memory for novel objects. After learning, the mice were either exposed to a period of rest, or a high interference condition. Emily showed that post-learning rest improves memory in mice – akin to the effect reported by Dewar and colleagues. This protocol is now being used to test a mouse model of Alzheimer’s disease for interference effects.

Michael Craig

Together, the researchers’ data provide a basis from which to design experiments to understand the neurophysiological, neurobiological and cognitive mechanisms underlying interference phenomena in Alzheimer’s disease. The researchers are immensely grateful to the Scottish Neuroprogressive and Dementia Network (NDN) for supporting their research.


Supporting innovation across NHS Scotland

Promoting and encouraging innovation within NHS Scotland is a key priority to drive the highest quality of healthcare and support new ways of working, faster access to services or new treatments. Scottish Health Innovations Ltd (SHIL) has worked closely with NHS Scotland since it was established in 2002. During this time SHIL has helped to identify, protect, develop and commercialise new ideas and innovations generated by healthcare professionals across NHS Scotland. Owned by Scottish Ministers, NHS Tayside and Golden Jubilee National Hospital, it is the only organisation set up to work alongside NHS Scotland to carry out commercialisation activities. Service Level Agreements exist with all NHS Scotland Health Boards and grant funding is provided by the Chief Scientist Office (CSO) of Scottish Government.

Successes are numerous with over 1500 ideas supported since inception, multiple spin-outs, and a range of innovations now in routine use across NHS Scotland. 

specialist advice and expertise offered by SHIL such as intellectual property and funding advice

submit ideas section for staff to send their ideas and innovations

showcase of innovative products now in use across NHS Scotland and beyond

case studies on successful spin-out companies from NHS Scotland

NHS Research Scotland


Innovation Award sponsored by:

NHSScotland is committed to delivering the highest quality healthcare services to the people of Scotland. The Scottish Health Awards promote recognition of those who work in and with NHS Scotland, especially staff who do an exceptional job and who are prepared to go that extra mile to deliver these services. Taking place on Thursday 3rd October, NHS Research Scotland and Scottish Health Innovations Ltd are proud to jointly sponsor the Innovation Award.

This award is for an individual, a group or a team developing innovative ways to improve the quality of healthcare and the health of the nation to bring about service improvements such as new ways of working, faster access to services or new treatments or technology or through research. Other award categories include: Support Worker Award

Young Achiever Award

Leader of the Year

Volunteers Award

Unsung Hero Award

Dentist Award

Midwife Award

Care for Mental Health Award

Nurse Award

Therapist Award

Integrated Care for Older People Award Doctor Award

Care for long term illness Award

Healthier Lifestyle Award

Top Team Award

Read more and nominate at Deadline for nominations is 1st September 2016


NHS Research Scotland (NRS) is a partnership of Scottish NHS Boards and the Chief Scientist Office of Scottish Government. Registered Number: GB 236303. Registered address: The Golden Jubilee National Hospital, Fourth Floor East, Agamemnon St, Clydebank, G81 4DY Published by NHS Research Scotland. All rights reserved. Material contained in this publication may not be reproduced in whole or part without prior permission of NHS Research Scotland (or other copyright owners). While every effort is made to ensure that the information given here is accurate, no legal responsibility is accepted for any errors, omissions or misleading statements.